Gene · 7791
Papers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,771
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling. | Proc Natl Acad Sci U S A | 2023 | 37844244 | PubTator, text mining | PubMed |
| Mechanobiology of portal hypertension. | JHEP Rep | 2023 | 37841641 | PubTator, text mining | PubMed |
| Impact of the Physical Cellular Microenvironment on the Structure and Function of a Model Hepatocyte Cell Line for Drug Toxicity Applications. | Cells | 2023 | 37830622 | PubTator, text mining | PubMed |
| Curved adhesions mediate cell attachment to soft matrix fibres in three dimensions. | Nat Cell Biol | 2023 | 37770566 | PubTator, text mining | PubMed |
| The Mechanotransduction Signaling Pathways in the Regulation of Osteogenesis. | Int J Mol Sci | 2023 | 37762629 | PubTator, text mining | PubMed |
| Characterisation of Lipoma-Preferred Partner as a Novel Mechanotransducer in Vascular Smooth Muscle Cells. | Cells | 2023 | 37759537 | PubTator, text mining | PubMed |
| Improving the accuracy of the FMO binding affinity prediction of ligand-receptor complexes containing metals. | J Comput Aided Mol Des | 2023 | 37743428 | PubTator, text mining | PubMed |
| Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin. | Front Endocrinol (Lausanne) | 2023 | 37732119 | PubTator, text mining | PubMed |
| Regulating Blood Clot Fibrin Films to Manipulate Biomaterial-Mediated Foreign Body Responses. | Research (Wash D C) | 2023 | 37719049 | PubTator, text mining | PubMed |
| azyx-1 is a new gene that overlaps with zyxin and affects its translation in C. elegans, impacting muscular integrity and locomotion. | PLoS Biol | 2023 | 37713439 | PubTator, text mining | PubMed |
| Zyxin inhibits the epithelial-mesenchymal transition process in gastric cancer by upregulating SIRT1. | MedComm (2020) | 2023 | 37667739 | PubTator, text mining | PubMed |
On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence. | Int J Mol Sci | 2023 | 37628858 | PubTator, text mining | PubMed |
| Targeted Therapy for EWS-FLI1 in Ewing Sarcoma. | Cancers (Basel) | 2023 | 37627063 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway. | Biomedicines | 2023 | 37626810 | PubTator, text mining | PubMed |
| Predictive value of serum proteomic biomarkers for noise-induced hearing loss. | Environ Sci Pollut Res Int | 2023 | 37582891 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia. | MedComm (2020) | 2023 | 37576864 | PubTator, text mining | PubMed |
| Editorial: Editorial for mechanical and structural phenotypes of cells and extracellular matrices govern cell adhesion and migration. | Front Cell Dev Biol | 2023 | 37576605 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures. | Cancers (Basel) | 2023 | 37568580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7791/papers?page=6